Last edition
News about "Bayer Kerendia FDA approval"
US FDA Approves Finerenone for CKD in Type 1 Diabetes
The US FDA has approved finerenone for a new indication: treating Chronic Kidney Disease associated with Type 1 Diabetes in patients.
Bayer Kerendia FDA Approval | 21/09/2026 | By News Bureau
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members